Table 2.
Change from baseline according to treatment group
Variable | Placebo (n=41) | Allopurinol (n=39) | P Value |
---|---|---|---|
Serum urate, mg/dl | 0.05±1.54 | −3.24±1.35 | <0.001 |
BA-FMD, % Δ | 0.2±4.1 | 0.9±3.9 | 0.47 |
NMD, % Δ | −1.3±5.3 | 0.9±6.1 | 0.14 |
Systolic BP, mmHg | −1.63±15.51 | −1.70±17.52 | 0.85 |
Diastolic BP, mmHg | −0.97±11.8 | 0.97±10.8 | 0.51 |
CRP, mg/L | 0.70±3.4 | 0.42±9.5 | 0.78 |
IL-6, pg/ml | 0.15±3.1 | 0.37±2.7 | 0.75 |
MCP-1, pg/ml | −4.7±45.8 | 3.6±36.7 | 0.47 |
Ox-LDL, U/L | −0.08±11.8 | −2.97±16.4 | 0.19 |
Value are expressed as absolute change from baseline±SD. BA-FMD % Δ, % change in BA-FMD; NMD % Δ, % change in NMD.